Product Information

DIFLUPREDNATE 0.05% EYE DROP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $8.0544 per ML under NDC 00832605405. Its NADAC has been published 51 times since Dec 3, 2025.

FDA first approved this application on Feb 11, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DIFLUPREDNATE 0.05% EYE DROP

Difluprednate
$8.0544per ML

Strength

.5 mg/mL

NDC

00832605405

Classification

Generic

Dosage Form

EMULSION

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

DIFLUPREDNATE

Approval Type

Generic (ANDA)

FDA Application

ANDA218191

FDA Approved

2/11/2025

TE Code

AB

On Market Since

2/21/2025

Price Statistics

The NADAC for DIFLUPREDNATE 0.05% EYE DROP has been published 51 times since Dec 3, 2025, and over the history we have for it it has declined 19.8%. The table below summarizes its recorded NADAC range and movement.

Current price$8.0544 per ML
All-time high$10.4599 (Feb 11, 2026)
All-time low$7.0479 (Jun 17, 2026)
52-week high$10.4599
52-week low$7.0479
Median price$9.0744
Average price$9.0138
Largest weekly change+20.4% (Aug 19, 2026)
Weeks tracked51
Tracking sinceDec 3, 2025

Price History

1W

-11.2%

1M

-16.8%

3M

-9.7%

6M

-0.7%

1Y

N/A

3Y

N/A

5Y

N/A

All

-19.8%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DIFLUPREDNATE 0.05% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for DIFLUPREDNATE 0.05% EYE DROP, manufactured by Upsher-Smith Laboratories LLC, is $8.0544 per ML (NDC 00832605405), effective Nov 18, 2026.

How has the price of DIFLUPREDNATE 0.05% EYE DROP changed over time?

Over the history we have for it, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has declined 19.8%. It has been tracked across 51 weekly CMS publications since Dec 3, 2025.

What are the highest and lowest recorded NADAC prices for DIFLUPREDNATE 0.05% EYE DROP?

Since Dec 3, 2025, the NADAC for DIFLUPREDNATE 0.05% EYE DROP has ranged from a low of $7.0479 (Jun 17, 2026) to a high of $10.4599 (Feb 11, 2026), with a median of $9.0744 per ML.

Are there cheaper alternatives to DIFLUPREDNATE 0.05% EYE DROP?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIFLUPREDNATE 0.05% EYE DROP in a comparable dosage form, but none are currently priced below it.

Who manufactures DIFLUPREDNATE 0.05% EYE DROP?

DIFLUPREDNATE 0.05% EYE DROP (NDC 00832605405) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.